We are live on ! Find out more
PNT

POINT Biopharma Global Inc. Common Stock
PNT

Delisted

PNT was delisted on the 26th of December, 2023.

Back to rankings

1 hedge funds and large institutions have $1K invested in POINT Biopharma Global Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 124 closing their positions.

New
Increased
Maintained
Reduced
Closed

18,472% more call options, than puts

Call options by funds: $8.54M | Put options by funds: $46K

99% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 124

99% less funds holding

Funds holding: 125 → 1 (-124)

100% less capital invested

Capital invested by funds: $411M → $1K (-$411M)

Holders
1
Holders Change
-124
Holders Change %
-99.2%
% of All Funds
0.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
124
Calls
$8.54M
Puts
$46K
Net Calls
+$8.5M
Net Calls Change
+$9.58M

Top Buyers

Rank Fund Capital Flow
1
BTI
Blue Trust Inc
Georgia
+$1.65K

Top Sellers

Rank Fund Capital Flow
1
BI
BVF Inc
California
-$70.5M
2
BlackRock
BlackRock
New York
-$44.3M
3
Vanguard Group
Vanguard Group
Pennsylvania
-$31.1M
4
State Street
State Street
Massachusetts
-$23.5M
5
GPP
Great Point Partners
Connecticut
-$19.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
Federated Hermes
26
Federated Hermes
Pennsylvania
– -$3.65M -547,433 Closed
JAM
27
Jupiter Asset Management
United Kingdom
– -$3.5M -524,079 Closed
Arrowstreet Capital
28
Arrowstreet Capital
Massachusetts
– -$3.49M -522,966 Closed
NCM
29
Nantahala Capital Management
Connecticut
– -$3.48M -521,191 Closed
Janus Henderson Group
30
Janus Henderson Group
United Kingdom
– -$2.61M -391,264 Closed
PAMP
31
Polar Asset Management Partners
Ontario, Canada
– -$2.53M -379,700 Closed
Bank of New York Mellon
32
Bank of New York Mellon
New York
– -$2.22M -332,610 Closed
Renaissance Technologies
33
Renaissance Technologies
New York
– -$2.18M -327,271 Closed
Bank of America
34
Bank of America
North Carolina
– -$2.05M -307,222 Closed
EHI
35
Eagle Health Investments
Connecticut
– -$2.04M -306,142 Closed
William Blair & Company
36
William Blair & Company
Illinois
– -$1.67M -250,528 Closed
BBA
37
Baker Bros. Advisors
New York
– -$1.67M -249,968 Closed
Goldman Sachs
38
Goldman Sachs
New York
– -$1.61M -242,071 Closed
Rafferty Asset Management
39
Rafferty Asset Management
New York
– -$1.49M -223,080 Closed
Connor, Clark & Lunn Investment Management (CC&L)
40
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
– -$1.43M -213,865 Closed
D.E. Shaw & Co
41
D.E. Shaw & Co
New York
– -$1.12M -167,955 Closed
RhumbLine Advisers
42
RhumbLine Advisers
Massachusetts
– -$982K -147,167 Closed
Barclays
43
Barclays
United Kingdom
– -$949K -142,257 Closed
Swiss National Bank
44
Swiss National Bank
Switzerland
– -$930K -139,366 Closed
BFS
45
Baskin Financial Services
Ontario, Canada
– -$887K -132,990 Closed
Invesco
46
Invesco
Georgia
– -$887K -132,977 Closed
AllianceBernstein
47
AllianceBernstein
Tennessee
– -$870K -130,450 Closed
Morgan Stanley
48
Morgan Stanley
New York
– -$855K -128,244 Closed
Qube Research & Technologies (QRT)
49
Qube Research & Technologies (QRT)
United Kingdom
– -$784K -117,587 Closed
MAM
50
Martingale Asset Management
Massachusetts
– -$677K -101,566 Closed
1
2
3 4 5

PNT Hedge Fund Activity: Q4 2023 in Review

1 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in POINT Biopharma Global Inc. Common Stock (PNT) for Q4 2023, worth a combined $1K — down 100% from $411M a quarter earlier.

Sellers outnumbered buyers: 124 funds closed out of PNT and 1 opened new positions — a net loss of 123 holders — while 0 trimmed existing stakes and 0 added.

The largest buyer was Blue Trust Inc, opening a new position worth an estimated $1.65K. The largest seller was BVF Inc, exiting entirely with an estimated $70.5M sold.

  • 1 institutional investor held POINT Biopharma Global Inc. Common Stock (PNT) as of Q4 2023, down from 125 in Q3 2023.
  • Funds reported $1K of POINT Biopharma Global Inc. Common Stock stock for Q4 2023, down 100% quarter-over-quarter.
  • 1 fund opened new POINT Biopharma Global Inc. Common Stock positions in Q4 2023 and 124 closed out, a net change of -123 holders.
  • The largest POINT Biopharma Global Inc. Common Stock buyer in Q4 2023 was Blue Trust Inc, an estimated $1.65K added.
  • The largest POINT Biopharma Global Inc. Common Stock seller in Q4 2023 was BVF Inc, an estimated $70.5M sold.

Based on aggregated 13F filings for Q4 2023.